Significant progress in understanding the immunopathogenesis of Leishmania infection has been made using inbred strains of mice. Resistance of Leishmania major has been correlated with the ability to expand and activate CD4+ T cells that produce IFN-gamma, the major macrophage activating factor identified in this disease. In contrast, susceptible mice expand CD4+ T cells that produce IL-4 and IL-10, cytokines that interfere with the production of IFN-gamma and the ability of IFN-gamma to activate target macrophages to kill the intracellular amastigotes. The characteristics of these disparate CD4+ T cell populations suggest that these cells represent in vivo correlates of Th1 and Th2 subsets described in studies of murine T cell clones. Limited studies in human populations suggest that similar findings may accompany human visceral leishmaniasis and that Th1 and Th2 subsets also occur among human CD4+ T cell clones. Susceptibility is not related to deletion of the requisite IFN-gamma- producing T cell clones, since a variety of immunologic manipulations made at the time of infection enables susceptible mice to heal with the establishment of Th1 cell populations. Adoptive transfer of parasite- specific Th1 and Th2 lines and clones has demonstrated that these cells constitute stable cell populations capable of mediating the full spectrum of susceptibility and resistance, in large part through the effector functions of the lymphokines secreted by these cells. Although these types of effector CD4+ subsets are being incriminated in increasing numbers of parasitic diseases, the mechanisms by which these subsets become established remain unknown. Studies using neutralizing monoclonal antibodies have identified key cytokines that must be present during the early periods after infection in order for Th1 or Th2 development to proceed, although studies using recombinant cytokines have been unable to reverse genetically predetermined outcomes. This proposal seeks to use Leishmania major infection in inbred strains of mice to develop methods to examine closely the early events that are critical to the development of Th1 and Th2 effector subsets. The strategy involves both analysis of early cytokine requirements and a direct approach to the identification of antigens implicated in CD4+ subset activation. There are three specific goals: 1. to use parasites transfected with cytokine genes to target critical immune molecules directly to the infected macrophage; 2. to establish whether Th1 and Th2 cells arise from a common precursor; and 3. to begin studies to sequence directly critical peptides from the parasite that are complexed to MHC class II molecules that are involved in activation of important Th1 and Th2 clones. These studies should provide important insights towards the understanding of Th1 and Th2 cell subset maturation and the characteristics of critical parasite antigens involved in this process.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI026918-07
Application #
2063629
Study Section
Bacteriology and Mycology Subcommittee 2 (BM)
Project Start
1988-07-01
Project End
1996-02-29
Budget Start
1994-07-01
Budget End
1996-02-29
Support Year
7
Fiscal Year
1994
Total Cost
Indirect Cost
Name
University of California San Francisco
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
073133571
City
San Francisco
State
CA
Country
United States
Zip Code
94143
Nusse, Ysbrand M; Savage, Adam K; Marangoni, Pauline et al. (2018) Parasitic helminths induce fetal-like reversion in the intestinal stem cell niche. Nature 559:109-113
Ricardo-Gonzalez, Roberto R; Van Dyken, Steven J; Schneider, Christoph et al. (2018) Tissue signals imprint ILC2 identity with anticipatory function. Nat Immunol 19:1093-1099
Nadjsombati, Marija S; McGinty, John W; Lyons-Cohen, Miranda R et al. (2018) Detection of Succinate by Intestinal Tuft Cells Triggers a Type 2 Innate Immune Circuit. Immunity 49:33-41.e7
Van Dyken, Steven J; Locksley, Richard M (2018) Chitins and chitinase activity in airway diseases. J Allergy Clin Immunol 142:364-369
Schneider, Christoph; O'Leary, Claire E; von Moltke, Jakob et al. (2018) A Metabolite-Triggered Tuft Cell-ILC2 Circuit Drives Small Intestinal Remodeling. Cell 174:271-284.e14
Miller, Corey N; Proekt, Irina; von Moltke, Jakob et al. (2018) Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte development. Nature 559:627-631
Van Dyken, Steven J; Liang, Hong-Erh; Naikawadi, Ram P et al. (2017) Spontaneous Chitin Accumulation in Airways and Age-Related Fibrotic Lung Disease. Cell 169:497-509.e13
Savage, Adam K; Liang, Hong-Erh; Locksley, Richard M (2017) The Development of Steady-State Activation Hubs between Adult LTi ILC3s and Primed Macrophages in Small Intestine. J Immunol 199:1912-1922
Singh, Priti B; Pua, Heather H; Happ, Hannah C et al. (2017) MicroRNA regulation of type 2 innate lymphoid cell homeostasis and function in allergic inflammation. J Exp Med 214:3627-3643
von Moltke, Jakob; O'Leary, Claire E; Barrett, Nora A et al. (2017) Leukotrienes provide an NFAT-dependent signal that synergizes with IL-33 to activate ILC2s. J Exp Med 214:27-37

Showing the most recent 10 out of 88 publications